IBDEI041 ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5092,2)
 ;;=^124650
 ;;^UTILITY(U,$J,358.3,5093,0)
 ;;=078.10^^33^370^79
 ;;^UTILITY(U,$J,358.3,5093,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5093,1,4,0)
 ;;=4^078.10
 ;;^UTILITY(U,$J,358.3,5093,1,5,0)
 ;;=5^Warts
 ;;^UTILITY(U,$J,358.3,5093,2)
 ;;=^295787
 ;;^UTILITY(U,$J,358.3,5094,0)
 ;;=706.8^^33^370^80
 ;;^UTILITY(U,$J,358.3,5094,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5094,1,4,0)
 ;;=4^706.8
 ;;^UTILITY(U,$J,358.3,5094,1,5,0)
 ;;=5^Xerosis
 ;;^UTILITY(U,$J,358.3,5094,2)
 ;;=^271931
 ;;^UTILITY(U,$J,358.3,5095,0)
 ;;=710.1^^33^370^60
 ;;^UTILITY(U,$J,358.3,5095,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5095,1,4,0)
 ;;=4^710.1
 ;;^UTILITY(U,$J,358.3,5095,1,5,0)
 ;;=5^Scleroderma
 ;;^UTILITY(U,$J,358.3,5095,2)
 ;;=Scleroderma^108590
 ;;^UTILITY(U,$J,358.3,5096,0)
 ;;=250.80^^33^370^72
 ;;^UTILITY(U,$J,358.3,5096,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5096,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,5096,1,5,0)
 ;;=5^Ulcer Of Calf, Diabetic
 ;;^UTILITY(U,$J,358.3,5096,2)
 ;;=Ulcer of Calf, Diabetic^267846^707.12
 ;;^UTILITY(U,$J,358.3,5097,0)
 ;;=695.10^^33^370^38
 ;;^UTILITY(U,$J,358.3,5097,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5097,1,4,0)
 ;;=4^695.10
 ;;^UTILITY(U,$J,358.3,5097,1,5,0)
 ;;=5^Erythema Multiforme,Unsp
 ;;^UTILITY(U,$J,358.3,5097,2)
 ;;=^336759
 ;;^UTILITY(U,$J,358.3,5098,0)
 ;;=695.11^^33^370^37
 ;;^UTILITY(U,$J,358.3,5098,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5098,1,4,0)
 ;;=4^695.11
 ;;^UTILITY(U,$J,358.3,5098,1,5,0)
 ;;=5^Erythema Multiforme, Minor
 ;;^UTILITY(U,$J,358.3,5098,2)
 ;;=^336634
 ;;^UTILITY(U,$J,358.3,5099,0)
 ;;=695.12^^33^370^36
 ;;^UTILITY(U,$J,358.3,5099,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5099,1,4,0)
 ;;=4^695.12
 ;;^UTILITY(U,$J,358.3,5099,1,5,0)
 ;;=5^Erythema Multiforme, Major
 ;;^UTILITY(U,$J,358.3,5099,2)
 ;;=^336635
 ;;^UTILITY(U,$J,358.3,5100,0)
 ;;=695.19^^33^370^39
 ;;^UTILITY(U,$J,358.3,5100,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5100,1,4,0)
 ;;=4^695.19
 ;;^UTILITY(U,$J,358.3,5100,1,5,0)
 ;;=5^Erythema, Other Multiforme
 ;;^UTILITY(U,$J,358.3,5100,2)
 ;;=^336639
 ;;^UTILITY(U,$J,358.3,5101,0)
 ;;=078.12^^33^370^51
 ;;^UTILITY(U,$J,358.3,5101,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5101,1,4,0)
 ;;=4^078.12
 ;;^UTILITY(U,$J,358.3,5101,1,5,0)
 ;;=5^Plantar Wart
 ;;^UTILITY(U,$J,358.3,5101,2)
 ;;=^336720
 ;;^UTILITY(U,$J,358.3,5102,0)
 ;;=695.13^^33^370^67
 ;;^UTILITY(U,$J,358.3,5102,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5102,1,4,0)
 ;;=4^695.13
 ;;^UTILITY(U,$J,358.3,5102,1,5,0)
 ;;=5^Steven-Johnson Syndrome
 ;;^UTILITY(U,$J,358.3,5102,2)
 ;;=^336636
 ;;^UTILITY(U,$J,358.3,5103,0)
 ;;=695.14^^33^370^59
 ;;^UTILITY(U,$J,358.3,5103,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5103,1,4,0)
 ;;=4^695.14
 ;;^UTILITY(U,$J,358.3,5103,1,5,0)
 ;;=5^SJS-TEN Syndrome
 ;;^UTILITY(U,$J,358.3,5103,2)
 ;;=^336637
 ;;^UTILITY(U,$J,358.3,5104,0)
 ;;=695.15^^33^370^70
 ;;^UTILITY(U,$J,358.3,5104,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5104,1,4,0)
 ;;=4^695.15
 ;;^UTILITY(U,$J,358.3,5104,1,5,0)
 ;;=5^Toxic Epidermal Necrolysis
 ;;^UTILITY(U,$J,358.3,5104,2)
 ;;=^336638
 ;;^UTILITY(U,$J,358.3,5105,0)
 ;;=V18.0^^33^371^17
 ;;^UTILITY(U,$J,358.3,5105,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5105,1,4,0)
 ;;=4^V18.0
 ;;^UTILITY(U,$J,358.3,5105,1,5,0)
 ;;=5^Family H/O Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,5105,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,5106,0)
 ;;=V16.0^^33^371^10
 ;;^UTILITY(U,$J,358.3,5106,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5106,1,4,0)
 ;;=4^V16.0
 ;;^UTILITY(U,$J,358.3,5106,1,5,0)
 ;;=5^Family H/O Cancer Of Gi Tract
 ;;^UTILITY(U,$J,358.3,5106,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,5107,0)
 ;;=V16.1^^33^371^11
 ;;^UTILITY(U,$J,358.3,5107,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5107,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,5107,1,5,0)
 ;;=5^Family H/O Cancer Of Lung
 ;;^UTILITY(U,$J,358.3,5107,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,5108,0)
 ;;=V19.6^^33^371^4
 ;;^UTILITY(U,$J,358.3,5108,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5108,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,5108,1,5,0)
 ;;=5^Family H/O Allergic Disorder
 ;;^UTILITY(U,$J,358.3,5108,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,5109,0)
 ;;=V18.2^^33^371^5
 ;;^UTILITY(U,$J,358.3,5109,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5109,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,5109,1,5,0)
 ;;=5^Family H/O Anemia
 ;;^UTILITY(U,$J,358.3,5109,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,5110,0)
 ;;=V17.5^^33^371^7
 ;;^UTILITY(U,$J,358.3,5110,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5110,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,5110,1,5,0)
 ;;=5^Family H/O Asthma
 ;;^UTILITY(U,$J,358.3,5110,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,5111,0)
 ;;=V17.7^^33^371^6
 ;;^UTILITY(U,$J,358.3,5111,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5111,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,5111,1,5,0)
 ;;=5^Family H/O Arthritis
 ;;^UTILITY(U,$J,358.3,5111,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,5112,0)
 ;;=V19.0^^33^371^8
 ;;^UTILITY(U,$J,358.3,5112,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5112,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,5112,1,5,0)
 ;;=5^Family H/O Blindness
 ;;^UTILITY(U,$J,358.3,5112,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,5113,0)
 ;;=V16.3^^33^371^9
 ;;^UTILITY(U,$J,358.3,5113,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5113,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,5113,1,5,0)
 ;;=5^Family H/O Cancer Of Breast
 ;;^UTILITY(U,$J,358.3,5113,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,5114,0)
 ;;=V16.41^^33^371^12
 ;;^UTILITY(U,$J,358.3,5114,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5114,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,5114,1,5,0)
 ;;=5^Family H/O Cancer Of Ovary
 ;;^UTILITY(U,$J,358.3,5114,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,5115,0)
 ;;=V16.42^^33^371^13
 ;;^UTILITY(U,$J,358.3,5115,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5115,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,5115,1,5,0)
 ;;=5^Family H/O Cancer Of Prostate
 ;;^UTILITY(U,$J,358.3,5115,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,5116,0)
 ;;=V16.43^^33^371^14
 ;;^UTILITY(U,$J,358.3,5116,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5116,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,5116,1,5,0)
 ;;=5^Family H/O Cancer Of Testis
 ;;^UTILITY(U,$J,358.3,5116,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,5117,0)
 ;;=V19.5^^33^371^15
 ;;^UTILITY(U,$J,358.3,5117,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5117,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,5117,1,5,0)
 ;;=5^Family H/O Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,5117,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,5118,0)
 ;;=V19.2^^33^371^16
 ;;^UTILITY(U,$J,358.3,5118,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5118,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,5118,1,5,0)
 ;;=5^Family H/O Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,5118,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,5119,0)
 ;;=V17.3^^33^371^18
 ;;^UTILITY(U,$J,358.3,5119,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5119,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,5119,1,5,0)
 ;;=5^Family H/O Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,5119,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,5120,0)
 ;;=V16.6^^33^371^19
 ;;^UTILITY(U,$J,358.3,5120,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5120,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,5120,1,5,0)
 ;;=5^Family H/O Leukemia
 ;;^UTILITY(U,$J,358.3,5120,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,5121,0)
 ;;=V18.61^^33^371^21
 ;;^UTILITY(U,$J,358.3,5121,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5121,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,5121,1,5,0)
 ;;=5^Family H/O Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,5121,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,5122,0)
 ;;=V17.0^^33^371^22
 ;;^UTILITY(U,$J,358.3,5122,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5122,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,5122,1,5,0)
 ;;=5^Family H/O Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,5122,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,5123,0)
 ;;=V19.4^^33^371^23
 ;;^UTILITY(U,$J,358.3,5123,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5123,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,5123,1,5,0)
 ;;=5^Family H/O Skin Condition
 ;;^UTILITY(U,$J,358.3,5123,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,5124,0)
 ;;=V17.1^^33^371^24
 ;;^UTILITY(U,$J,358.3,5124,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5124,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,5124,1,5,0)
 ;;=5^Family H/O Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,5124,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,5125,0)
 ;;=V16.8^^33^371^20
 ;;^UTILITY(U,$J,358.3,5125,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5125,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,5125,1,5,0)
 ;;=5^Family H/O Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,5125,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,5126,0)
 ;;=V11.1^^33^371^47
 ;;^UTILITY(U,$J,358.3,5126,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5126,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,5126,1,5,0)
 ;;=5^Personal H/O Affective Disorder
 ;;^UTILITY(U,$J,358.3,5126,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,5127,0)
 ;;=V15.89^^33^371^55
 ;;^UTILITY(U,$J,358.3,5127,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5127,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,5127,1,5,0)
 ;;=5^Personal H/O Exposure To Persian Gulf Region
 ;;^UTILITY(U,$J,358.3,5127,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,5128,0)
 ;;=V11.3^^33^371^48
 ;;^UTILITY(U,$J,358.3,5128,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5128,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,5128,1,5,0)
 ;;=5^Personal H/O Alcoholism
 ;;^UTILITY(U,$J,358.3,5128,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,5129,0)
 ;;=V15.07^^33^371^49
 ;;^UTILITY(U,$J,358.3,5129,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5129,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,5129,1,5,0)
 ;;=5^Personal H/O Allergy to Latex
 ;;^UTILITY(U,$J,358.3,5129,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,5130,0)
 ;;=V13.4^^33^371^50
 ;;^UTILITY(U,$J,358.3,5130,1,0)
 ;;=^358.31IA^5^2
